Tag: pediatric rare disease gene therapy age limits
How to Qualify for US Rare Disease Gene Therapy in 2024: FDA-Aligned Eligibility Checklist for Adults, Pediatrics & Patients With Comorbidities
Per October 2024 FDA guidance, 2024 National Organization for Rare Disorders (NORD) data, and CMS 2024 specialty therapy rules, only 5% of U.S. rare disease patients currently access life-saving gene therapies. This premium FDA-aligned eligibility buying guide beats counterfeit unvetted online checklists, with a 5-step verified framework for adults, pediatrics, and patients with comorbidities. It